Raiffeisen Bank International AG
Source: SEC Form 13F · as of Mar 2026Raiffeisen Bank International AG holds 20 biotech & pharma companies tracked by BioSniper, totaling $63.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$63.2M
BioSniper AIPage context preserved
Prepared research question
What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 180,757 | $24.6M |
| REGNREGENERON PHARMACEUTICALS, INC. | 23,203 | $17.4M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 10,413 | $3.3M |
| IONSIONIS PHARMACEUTICALS INC | 36,000 | $2.6M |
| RVMDREVOLUTION MEDICINES, INC. | 26,000 | $2.4M |
| RLAYRelay Therapeutics, Inc. | 190,000 | $1.8M |
| ARDXARDELYX, INC. | 300,000 | $1.7M |
| JAZZJazz Pharmaceuticals plc | 8,000 | $1.5M |
| IOVAIOVANCE BIOTHERAPEUTICS, INC. | 380,000 | $1.3M |
| TLXTelix Pharmaceuticals Limited | 130,000 | $1.2M |
| BEAMBeam Therapeutics Inc. | 45,000 | $986K |
| TEVATeva Pharmaceutical Industries Limited | 31,844 | $903K |
| NGNENeurogene Inc. | 43,000 | $830K |
| VKTXViking Therapeutics, Inc. | 26,000 | $778K |
| BMRNBIOMARIN PHARMACEUTICAL INC | 14,000 | $767K |
| OCULOCULAR THERAPEUTIX, INC | 95,000 | $703K |
| RXRXRECURSION PHARMACEUTICALS, INC. | 160,000 | $454K |
| ARGXARGENX SE | 100 | $70K |
| INSMINSMED Inc | 184 | $28K |
| INCYIncyte Corp. | 221 | $20K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.